Historical record - last NADAC publication: 1/1/2018
Product Information
CAVERJECT 40 MCG VIAL is a brand product labeled by Pharmacia & Upjohn Company LLC, priced at $125.1112 per EA under NDC 00009768604. Its NADAC has been published 269 times since Nov 28, 2013.
Strength
41.1 ug/mL
Manufacturer
Pharmacia & Upjohn Company LLCNDC
00009768604
Classification
Brand
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRACAVERNOUS
Last Updated
1/1/2018
Active Ingredients
ALPROSTADILApproval Type
New Drug (NDA)
FDA Application
NDA020379On Market Since
7/6/1995
Pharmacological Classes
Price Statistics
The NADAC for CAVERJECT 40 MCG VIAL has been published 269 times since Nov 28, 2013, and over the history we have for it it has risen 108.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $125.1112 per EA |
|---|---|
| All-time high | $125.1112 (Jan 16, 2019) |
| All-time low | $60.0241 (Nov 28, 2013) |
| Median price | $95.4483 |
| Average price | $93.6082 |
| Largest weekly change | +9.4% (Jun 10, 2015) |
| Weeks tracked | 269 |
| Tracking since | Nov 28, 2013 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Alprostadil market page.
Lowest-Cost Alternatives
No alternatives available
Frequently asked questions
What is the NADAC price of CAVERJECT 40 MCG VIAL?
The current National Average Drug Acquisition Cost (NADAC) for CAVERJECT 40 MCG VIAL, manufactured by Pharmacia & Upjohn Company LLC, is $125.1112 per EA (NDC 00009768604), effective Jan 16, 2019.
How has the price of CAVERJECT 40 MCG VIAL changed over time?
Over the history we have for it, the NADAC for CAVERJECT 40 MCG VIAL has risen 108.4%. It has been tracked across 269 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for CAVERJECT 40 MCG VIAL?
Since Nov 28, 2013, the NADAC for CAVERJECT 40 MCG VIAL has ranged from a low of $60.0241 (Nov 28, 2013) to a high of $125.1112 (Jan 16, 2019), with a median of $95.4483 per EA.
Are there cheaper alternatives to CAVERJECT 40 MCG VIAL?
No other NADAC-published product currently shares the active ingredient, strength, and dosage form of CAVERJECT 40 MCG VIAL, so no direct lower-cost alternative is listed.
Who manufactures CAVERJECT 40 MCG VIAL?
CAVERJECT 40 MCG VIAL (NDC 00009768604) is labeled by Pharmacia & Upjohn Company LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification